Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LTA4H | P09960 | 1/20 | 0.52 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.52 |
| ▸ | DPP4 | P27487 | 4/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | GLA | P06280 | 2/20 | 0.48 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | HPGD | P15428 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | POLB | P06746 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | CASP1 | P29466 | 2/20 | 0.47 |
| ▸ | CASP7 | P55210 | 2/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL498603 | 0.98 | DPP4 (0.53) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| SCHEMBL4340697 | 0.84 | SNCA (0.46) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| Alpha-Terthienyl SCHEMBL147274 | 0.83 | DPP4 (0.65) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| SCHEMBL2742433 | 0.83 | DPP4 (0.65) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| SCHEMBL14703073 | 0.83 | DPP4 (0.65) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| SCHEMBL23611278 | 0.83 | DPP4 (0.65) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| SCHEMBL1105086 | 0.83 | DPP4 (0.65) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| SCHEMBL499333 | 0.83 | DPP4 (0.65) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| SCHEMBL13707354 | 0.83 | DPP4 (0.65) | LTA4HHDAC1DPP4ALDH1A1KDM4E | |
| SCHEMBL13707359 | 0.83 | DPP4 (0.65) | LTA4HHDAC1DPP4ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 202 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115368351-B | Preparation method and application of polysubstituted oxazole compound | 广东工业大学 | 2025-03-25 | — | — | CN | claimed |
| WO-2021019559-A1 | SYNTHESIS OF 5-(3-PYRIDYL)-2,2'-BITHIOPHENE(SENSITIZER) | FERMENTA BIOTECH LIMITED (IN) | 2021-02-04 | — | — | WO | claimed |
| CN-111592739-A | Preparation method of electromagnetic shielding plastic | 湖南七纬科技有限公司 | 2020-08-28 | — | — | CN | claimed |
| CN-108912614-B | Electromagnetic shielding plastic and preparation method thereof | 广东佳瑞达科技有限公司 | 2020-08-18 | — | — | CN | claimed |
| EP-2617754-A1 | FLUORENE CONTAINING ORGANIC SEMICONDUCTOR MATERIAL, PREPARATION METHOD AND USE THEREOF | Ocean's King Lighting Science&Technology Co., Ltd. (CN) | 2013-07-24 | — | — | EP | claimed |
| US-20260035592-A1 | CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL PHOTOFABRICATION AND METHOD FOR PRODUCING THREE-DIMENSIONAL PHOTOFABRICATED PRODUCT | TOKUYAMA DENTAL CORPORATION (JP) | 2026-02-05 | — | — | US | disclosed |
| CN-115368351-B | Preparation method and application of polysubstituted oxazole compound | 广东工业大学 | 2025-03-25 | — | — | CN | disclosed |
| US-12202954-B2 | Rubber composition and crosslinked rubber molded product | SUMITOMO RUBBER INDUSTRIES, LTD. (JP) | 2025-01-21 | — | — | US | disclosed |
| US-20240199882-A1 | THIENYL-DIBENZOAZEPINES AND THEIR DERIVATIVES AS DONORS FOR XANTHENE-BASED SHORT-WAVE INFRARED (SWIR) DYES | MISSISSIPPI STATE UNIVERSITY (US) | 2024-06-20 | — | — | US | disclosed |
| WO-2024038705-A1 | CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR 3D STEREOLITHOGRAPHY AND METHOD FOR PRODUCING 3D STEREOLITHOGRAPHY PRODUCT | 株式会社トクヤマデンタル | 2024-02-22 | — | — | WO | disclosed |
| CN-116987097-A | Organic conjugated molecule based on D-A-D type near infrared two-region emission and preparation method and application thereof | 北京化工大学 | 2023-11-03 | — | — | CN | disclosed |
| US-11773074-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-10-03 | — | — | US | disclosed |
| EP-0819125-A1 | THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1998-01-21 | — | — | EP | disclosed |
| US-5594021-A | VASOCONSTRICTORS | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1997-01-14 | — | — | US | disclosed |
| US-5591761-A | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1997-01-07 | — | — | US | disclosed |
| US-5571821-A | CARDIOVASCULAR DISORDERS TO MODULATE ENDOTHELIN, HYPOTENSIVE AGENTS AND VASOCONSTRICTION | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-11-05 | — | — | US | disclosed |
| WO-1996031492-A1 | THIENYL-, FURYL-, PYRROLYL- AND BIPHENYLSULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-10-10 | — | — | WO | disclosed |
| US-5546889-A | Method of manufacturing organic oriented film and method of manufacturing electronic device | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JP) | 1996-08-20 | — | — | US | disclosed |
| EP-0699191-A1 | SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | TEXAS BIOTECHNOLOGY CORPORATION (US) | 1996-03-06 | — | — | EP | disclosed |
| WO-1994027979-A1 | SULFONAMIDES AND DERIVATIVES THEREOF THAT MODULATE THE ACTIVITY OF ENDOTHELIN | IMMUNOPHARMACEUTICS, INC. (US) | 1994-12-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773074-B2 | Method for aerobic oxidative coupling of thiophenes with a ligand-supported palladium catalyst | PPOX, TST, COX6C | LTA4H 2216/4885HDAC1 3582/4885DPP4 1694/4885 |
| US-20260035592-A1 | CATIONICALLY POLYMERIZABLE RESIN COMPOSITION FOR THREE-DIMENSIONAL PHOTOFABRICATION AND METHOD FOR PRODUCING THREE-DIMENSIONAL PHOTOFABRICATED PRODUCT | TERB1, CAD, C9 | LTA4H 199/4885HDAC1 1506/4885DPP4 3718/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.